Xigris (Eli Lilly en es it fr

Xigris (Eli Lilly Brand names, Xigris (Eli Lilly Analogs

Xigris (Eli Lilly Brand Names Mixture

  • No information avaliable

Xigris (Eli Lilly Chemical_Formula

C1786H2779N509O519S29

Xigris (Eli Lilly RX_link

http://www.rxlist.com/cgi/generic/drotrecogin.htm

Xigris (Eli Lilly fda sheet

Xigris (Eli Lilly msds (material safety sheet)

Xigris (Eli Lilly Synthesis Reference

No information avaliable

Xigris (Eli Lilly Molecular Weight

55000

Xigris (Eli Lilly Melting Point

No information avaliable

Xigris (Eli Lilly H2O Solubility

No information avaliable

Xigris (Eli Lilly State

Liquid

Xigris (Eli Lilly LogP

-0.291

Xigris (Eli Lilly Dosage Forms

Powder for solution

Xigris (Eli Lilly Indication

For treatment of severe sepsis

Xigris (Eli Lilly Pharmacology

Activated Protein C exerts an antithrombotic effect by inhibiting (cleaving) Factors Va and VIIIa. In vitro data indicate that Activated Protein C has indirect profibrinolytic activity through its ability to inhibit plasminogen activator inhibitor-1 (PAI-1) and limiting generation of activated thrombin-activatable-fibrinolysis-inhibitor. The net effect is the reduction or elimination of blood clots

Xigris (Eli Lilly Absorption

No information avaliable

Xigris (Eli Lilly side effects and Toxicity

No information avaliable

Xigris (Eli Lilly Patient Information

No information avaliable

Xigris (Eli Lilly Organisms Affected

Humans and other mammals